4 completed, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
Follow Pracinostat: new trials by email Literature Review of Pracinostat trials Research Report on Pracinostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes Pracinostat, Azacitidine - Myelodysplastic Syndromes | Phase 2 | Terminated | Helsinn Healthcare SA | 64 | 2017-06-01 | 2022-03-02 |
| Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF) Ruxolitinib, Pracinostat, Questionnaire - Myeloproliferative Diseases | Phase 2 | Completed | M.D. Anderson Cancer Center | 25 | 2015-01-12 | 2019-06-12 |
| Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Pracinostat, Azacitidine - Acute Myeloid Leukemia | Phase 2 | Completed | Helsinn Healthcare SA | 50 | 2013-12-24 | 2021-02-09 |
| Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA pracinostat, Azacitidine, Decitabine - Myelodysplastic Syndrome, MDS | Phase 2 | Completed | Helsinn Healthcare SA | 45 | 2013-12-01 | 2017-02-23 |
| Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome pracinostat, Placebo, Azacitidine - Myelodysplastic Syndrome | Phase 2 | Completed | Helsinn Healthcare SA | 102 | 2013-06-01 | 2018-09-13 |
Myelodysplastic Syndromes (3) · Leukemia, Myeloid, Acute (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1)
Helsinn Healthcare SA (4) · M.D. Anderson Cancer Center (1)
United States (5)
Guillermo Garcia-Manero, MD (3) · Ehab Atallah, MD (1) · Richard Ghalie, MD (1) · Srdan Verstovsek, MD (1)